SEARCH

SEARCH BY CITATION

References

  • 1
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995; 96:224230. MEDLINE
  • 2
    Herion D, Hoofnagle JH. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology 1997; 25:769771. MEDLINE
  • 3
    Gale MJ, Korth MJ, Tang NM, Tan S-L, Hopkins DA, Dever TE, Polyak SJ, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997; 230:217227. MEDLINE
  • 4
    Gale MJ, Blakely CM, Kwieciszewski B, Tan S-L, Dossett M, Tang NM, Korth MJ, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Bio 1998; 18:52085218.
  • 5
    Tan S-L, Nakao H, He Y, Vijaysri S, Neddermann P, Jacobs BL, Mayer BJ, et al. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 1999; 96:55335538. MEDLINE
  • 6
    David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC, Johnson GR. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requiremant for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem 1996; 271:91859188. MEDLINE
  • 7
    Chung JK, Uchida E, Grammar TC, Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Bio 1997; 17:65086516.
  • 8
    Duverlie G, Khorsi H, Castelain S, Jailon O, Izopet J, Lunel F, Eb F, et al. Sequence analysis of the NS5A protein of European hepatitis C virus isolates and relation to interferon sensitivity. J Gen Virol 1998; 79:13731381. MEDLINE
  • 9
    Polyak SJ, Paschal DM, McArdle S, Gale MJ, Moradpour D, Gretch DR. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 1999; 29:12621271. MEDLINE
  • 10
    Taylor DR, Shi ST, Romano PR, Barber GN, Lai MMC. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999; 285:107110. MEDLINE
  • 11
    Gale MJ, Kwieciszewski B, Dossett M, Nakao H, Katze MG. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 1999; 73:65066516. MEDLINE
  • 12
    Francois C, Duverlie G, Rebouillat D, Khorsi H, Castelain S, Blum HE, Gatignol A, et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J Virol 2000; 74:55875596. MEDLINE
  • 13
    Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290:19721974. MEDLINE
  • 14
    Taylor DR, Shi ST, Romano PR, Barber GN, Lai MMC. Hepatitis C virus, the E2 envelope protein, and α-interferon resistance. Science 2000; 287:1555. MEDLINE